| Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis SH Gillespie, AM Crook, TD McHugh, CM Mendel, SK Meredith, ... New England Journal of Medicine 371 (17), 1577-1587, 2014 | 720 | 2014 |
| Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective SH Gillespie Antimicrobial agents and chemotherapy 46 (2), 267-274, 2002 | 713 | 2002 |
| Routine use of microbial whole genome sequencing in diagnostic and public health microbiology CU Köser, MJ Ellington, EJP Cartwright, SH Gillespie, NM Brown, ... Public Library of Science 8 (8), e1002824, 2012 | 657 | 2012 |
| Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial C Chintu, GJ Bhat, AS Walker, V Mulenga, F Sinyinza, K Lishimpi, ... The Lancet 364 (9448), 1865-1871, 2004 | 480 | 2004 |
| BTS recommendations for assessing risk, and for managing M. tuberculosis infection and disease, in patients due to start anti-TNF treatment P Ormerod, HJ Milburn, S Gillespie, J Ledingham, D Rampton Thorax, 2005 | 452 | 2005 |
| New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects AI Zumla, SH Gillespie, M Hoelscher, PPJ Philips, ST Cole, I Abubakar, ... The Lancet infectious diseases 14 (4), 327-340, 2014 | 423 | 2014 |
| The bacteriology of pleural infection by genetic and standard methods and its mortality significance NA Maskell, S Batt, EL Hedley, CWH Davies, SH Gillespie, RJO Davies American journal of respiratory and critical care medicine 174 (7), 817-823, 2006 | 421 | 2006 |
| High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial MJ Boeree, N Heinrich, R Aarnoutse, AH Diacon, R Dawson, S Rehal, ... The Lancet infectious diseases 17 (1), 39-49, 2017 | 391 | 2017 |
| A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis MJ Boeree, AH Diacon, R Dawson, K Narunsky, J Du Bois, A Venter, ... American journal of respiratory and critical care medicine 191 (9), 1058-1065, 2015 | 365 | 2015 |
| Physiological Cost of Rifampin Resistance Induced In Vitro in Mycobacterium tuberculosis OJ Billington, TD McHugh, SH Gillespie Antimicrobial agents and chemotherapy 43 (8), 1866-1869, 1999 | 339 | 1999 |
| Why do we use 600 mg of rifampicin in tuberculosis treatment? J Van Ingen, RE Aarnoutse, PR Donald, AH Diacon, R Dawson, ... Clinical Infectious Diseases 52 (9), e194-e199, 2011 | 305 | 2011 |
| The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis RD Gosling, LO Uiso, NE Sam, E Bongard, EG Kanduma, M Nyindo, ... American journal of respiratory and critical care medicine 168 (11), 1342-1345, 2003 | 254 | 2003 |
| Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study JM Bryant, SR Harris, J Parkhill, R Dawson, AH Diacon, P van Helden, ... The Lancet Respiratory Medicine 1 (10), 786-792, 2013 | 238 | 2013 |
| Principles and practice of clinical bacteriology SH Gillespie, PM Hawkey John Wiley & Sons, 2006 | 235 | 2006 |
| Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment SO Friedrich, A Rachow, E Saathoff, K Singh, CD Mangu, R Dawson, ... The lancet Respiratory medicine 1 (6), 462-470, 2013 | 215 | 2013 |
| Medical microbiology illustrated SH Gillespie Butterworth-Heinemann, 2014 | 200 | 2014 |
| Anti-tuberculosis medication and the liver: dangers and recommendations in management NP Thompson, ME Caplin, MI Hamilton, SH Gillespie, SW Clarke, ... European Respiratory Journal 8 (8), 1384-1388, 1995 | 199 | 1995 |
| Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution T Yeghen, CC Kibbler, HG Prentice, LA Berger, RK Wallesby, ... Clinical infectious diseases 31 (4), 859-868, 2000 | 198 | 2000 |
| Blood culture bottle culture of pleural fluid in pleural infection SM Menzies, NM Rahman, JM Wrightson, HE Davies, R Shorten, ... Thorax 66 (8), 658-662, 2011 | 186 | 2011 |
| Molecular epidemiology of tuberculosis in London 1995–7 showing low rate of active transmission H Maguire, JW Dale, TD McHugh, PD Butcher, SH Gillespie, A Costetsos, ... Thorax 57 (7), 617-622, 2002 | 185 | 2002 |
